Associations of childhood adiposity with adult intima–media thickness and inflammation: a 20-year longitudinal population-based cohort
暂无分享,去创建一个
B. Heude | F. Zannad | P. Rossignol | E. Bozec | N. Girerd | K. Duarte | E. Bresso | P. Scherdel | Tomona Fujikawa | S. Wagner | M. Kobayashi | Vincent Dupont
[1] M. Domingo,et al. Biomarkers in Heart Failure with Preserved Ejection Fraction , 2022, Cardiac failure review.
[2] P. Ridker,et al. Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease , 2021, Circulation research.
[3] A. Ba-Ssalamah,et al. Circulating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patients , 2021, International Journal of Obesity.
[4] Chiadi E. Ndumele,et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association , 2021, Circulation.
[5] M. Schwartz,et al. Fibronectin‐Mediated Inflammatory Signaling Through Integrin α5 in Vascular Remodeling , 2021, bioRxiv.
[6] S. Heymans,et al. Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF. , 2020, JACC. Heart failure.
[7] OUP accepted manuscript , 2021, Cardiovascular Research.
[8] E. Blaak,et al. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver , 2020, Nature Reviews Endocrinology.
[9] P. Jagodziński,et al. Association of rs699947 (−2578 C/A) and rs2010963 (−634 G/C) Single Nucleotide Polymorphisms of the VEGF Gene, VEGF-A and Leptin Serum Level, and Cardiovascular Risk in Patients with Excess Body Mass: A Case–Control Study , 2020, Journal of clinical medicine.
[10] M. Devignes,et al. Insulin-like growth factor binding protein 2: A prognostic biomarker for heart failure hardly redundant with natriuretic peptides. , 2019, International journal of cardiology.
[11] R. Vettor,et al. The Endothelium in Acromegaly , 2019, Front. Endocrinol..
[12] N. Faucheux,et al. Effect of BMP-9 on endothelial cells and its role in atherosclerosis. , 2019, Frontiers in bioscience.
[13] Stefan Konigorski,et al. Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. , 2019, Metabolism: clinical and experimental.
[14] Damian Szklarczyk,et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..
[15] F. Zannad,et al. Association between abdominal adiposity and 20-year subsequent aortic stiffness in an initially healthy population-based cohort , 2018, Journal of hypertension.
[16] T. Lehtimäki,et al. Distinct child-to-adult body mass index trajectories are associated with different levels of adult cardiometabolic risk , 2018, European heart journal.
[17] K. Reue,et al. Sex differences in obesity, lipid metabolism, and inflammation—A role for the sex chromosomes? , 2018, Molecular metabolism.
[18] Stefan Enroth,et al. Systemic and specific effects of antihypertensive and lipid-lowering medication on plasma protein biomarkers for cardiovascular diseases , 2018, Scientific Reports.
[19] F. Zannad,et al. Cohort Profile: Rationale and design of the fourth visit of the STANISLAS cohort: a familial longitudinal population-based cohort from the Nancy region of France. , 2018, International journal of epidemiology.
[20] Henning Hermjakob,et al. Reactome graph database: Efficient access to complex pathway data , 2018, PLoS Comput. Biol..
[21] D. Mozaffarian,et al. Addressing the Perfect Storm: Biomarkers in Obesity and Pathophysiology of Cardiometabolic Risk. , 2018, Clinical chemistry.
[22] H. Parving,et al. Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies , 2017, Cardiovascular Diabetology.
[23] P. Libby,et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.
[24] M. Netea,et al. IGF1 potentiates the pro-inflammatory response in human peripheral blood mononuclear cells via MAPK. , 2017, Journal of molecular endocrinology.
[25] A. Leite-Moreira,et al. Worse cardiac remodeling in response to pressure overload in type 2 diabetes mellitus. , 2016, International journal of cardiology.
[26] S. Hadjiyannakis,et al. LMS tables for waist-circumference and waist-height ratio Z-scores in children aged 5–19 y in NHANES III: association with cardio-metabolic risks , 2015, Pediatric Research.
[27] P. Whincup,et al. Lifelong patterns of BMI and cardiovascular phenotype in individuals aged 60-64 years in the 1946 British birth cohort study: an epidemiological study. , 2014, The lancet. Diabetes & endocrinology.
[28] T. Lehtimäki,et al. Prospective Relationship of Change in Ideal Cardiovascular Health Status and Arterial Stiffness: The Cardiovascular Risk in Young Finns Study , 2014, Journal of the American Heart Association.
[29] D. Lawlor,et al. Childhood obesity and vascular phenotypes: a population study. , 2012, Journal of the American College of Cardiology.
[30] T. Cole,et al. Extended international (IOTF) body mass index cut‐offs for thinness, overweight and obesity , 2012, Pediatric obesity.
[31] Jos W. M. van der Meer,et al. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases , 2012, Nature Reviews Drug Discovery.
[32] L. Folkersen,et al. The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of IGF binding protein-1 in the regulation of smooth muscle cell proliferation. , 2012, Atherosclerosis.
[33] Terence Dwyer,et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. , 2011, The New England journal of medicine.
[34] C. Dinarello,et al. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. , 2011, Blood.
[35] J. Floras,et al. Endothelial function, carotid-femoral stiffness, and plasma matrix metalloproteinase-2 in men with bicuspid aortic valve and dilated aorta. , 2010, Journal of the American College of Cardiology.
[36] Terho Lehtimäki,et al. Conventional Cardiovascular Risk Factors and Metabolic Syndrome in Predicting Carotid Intima-Media Thickness Progression in Young Adults: The Cardiovascular Risk in Young Finns Study , 2009, Circulation.
[37] L. Ghiadoni,et al. Osteopontin Is Associated with Increased Arterial Stiffness in Rheumatoid Arthritis , 2009, Molecular medicine.
[38] P. Libby,et al. Obesity, inflammation, and atherosclerosis , 2009, Nature Reviews Cardiology.
[39] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[40] J. Polak,et al. Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[41] A. Ferrante,et al. Obesity‐induced inflammation: a metabolic dialogue in the language of inflammation , 2007, Journal of internal medicine.
[42] E. Barrett-Connor,et al. Association of interleukin-6 and C-reactive protein with subclinical carotid atherosclerosis (the Rancho Bernardo Study). , 2007, The American journal of cardiology.
[43] H. Struijker‐Boudier,et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.
[44] C. Papamichael,et al. Impact of Obesity in Intima Media Thickness of Carotid Arteries , 2006, Obesity.
[45] J. Ruidavets,et al. Interleukin 6 is associated with subclinical atherosclerosis: a link with soluble intercellular adhesion molecule 1 , 2006, Journal of hypertension.
[46] T. Lobstein,et al. Worldwide trends in childhood overweight and obesity. , 2006, International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity.
[47] C. Papamichael,et al. Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness. , 2005, The Journal of pediatrics.
[48] Yasmin,et al. Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[49] Claude Lenfant,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[50] S. Grundy,et al. National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .
[51] J. Dawson,et al. Carotid Intimal-Medial Thickness Is Related to Cardiovascular Risk Factors Measured From Childhood Through Middle Age: The Muscatine Study , 2001, Circulation.
[52] T. Cole,et al. Establishing a standard definition for child overweight and obesity worldwide: international survey , 2000, BMJ : British Medical Journal.
[53] M. Safar,et al. Influence of body height on pulsatile arterial hemodynamic data. , 1998, Journal of the American College of Cardiology.
[54] A. Folsom,et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.
[55] R. Hruban,et al. Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. , 1992, The American journal of cardiology.
[56] J. Salonen,et al. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[57] O. de Divitiis,et al. Obesity and Cardiac Function , 1981, Circulation.
[58] G. Schwartz,et al. A Simple Estimate of Glomerular Filtration Rate in Children Derived From Body Length and Plasma Creatinine , 1976, Pediatrics.